Alkaline single-cell gel electrophoresis and human biomonitoring for genotoxicity: A pilot study on breast cancer patients undergoing chemotherapy including cyclophosphamide

Mutation Research - Genetic Toxicology and Environmental Mutagenesis

Volumn 395, Issue 2-3, 1997, Pages 127-138

  Vaghef, Hamid ^a,b   Nygren, Peter ^a   Edling, Christer ^a   Bergh, Jonas ^a   Hellman, Björn ^a,b  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^b UPPSALA UNIVERSITY   (Sweden)

Author keywords

Breast cancer; Cancer chemotherapy; Comet assay; Cyclophosphamide; Human biomonitoring; Peripheral lymphocyte; Primary DNA damage

Indexed keywords

CYCLOPHOSPHAMIDE; EPIRUBICIN; FLUOROURACIL; METHOTREXATE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BIOLOGICAL MONITORING; BREAST CANCER; CANCER CHEMOTHERAPY; CLINICAL ARTICLE; DNA DAMAGE; FEMALE; GEL ELECTROPHORESIS; GENOTOXICITY; HUMAN; INTRAPERITONEAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MOUSE; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL;

ADULT; ANIMALS; ANTINEOPLASTIC AGENTS, ALKYLATING; BREAST NEOPLASMS; CYCLOPHOSPHAMIDE; DNA DAMAGE; ELECTROPHORESIS; FEMALE; HUMANS; LYMPHOCYTES; MICE; MICE, INBRED C57BL; MIDDLE AGED; MUTAGENICITY TESTS; MUTAGENS; PILOT PROJECTS; REPRODUCIBILITY OF RESULTS; TIME FACTORS;

ANIMALIA;

EID: 0031566033     PISSN: 13835718     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1383-5718(97)00157-5     Document Type: Article

References (44)

1. Hellman B., Vaghef H., Friis L., Edling C. Alkaline single-cell gel electrophoresis of DNA fragments in biomonitoring for genotoxicity: an introductory study on healthy human volunteers. Int. Arch. Occup. Environ. Health. 69:1997;185-192.
2. International Agency for Research on Cancer, IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans. Vol. 26: Some Antineoplastic Agents and Immunosuppressive Agents, IARC, Lyon, 1981.
3. International Agency for Research on Cancer, IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans. Suppl. 7: Overall Evaluation of Carcinogenicity: An Updating of IARC Monographs Volumes 1 to 42, IARC, Lyon, 1987.
4. Hollstein M., McCann J., Angelsanto F.A., Nichols W.W. Short-term tests for carcinogens and mutagens. Mutation Res. 65:1979;133-226.
5. Hoffmann L., Möller P., Pedersen-Bjergaard J., Waage A., Pedersen M., Hirsch F. Therapy-related acute promyelocytic leukemia with t(15;17) (q22;q12) following chemotherapy with drugs targeting DNA topoisomerase II. A report of two cases and a review of the literature. Ann. Oncol. 6:1995;781-788.
6. Cremin P., Flattery M., McCann S., Daly P. Myelodysplasia and acute myeloid leukaemia following adjuvant chemotherapy for breast cancer using mitoxantrone and methotrexate with or without mitomycin. Annals Oncol. 7:1996;745-746.
7. Valagussa P., Moliterni A., Terenziani M., Zambetti M., Bonadonna G. Second malignancies following CMF-based adjuvant chemotherapy in resectable breast cancer. Ann. Oncol. 5:1994;803-808.
8. Vaghef H., Wisén A.-C., Hellman B. Demonstration of benzo(a)pyrene-induced DNA damage in mice by alkaline single-cell gel electrophoresis: Evidence for strand breaks in liver but not in lymphocytes and bone marrow. Pharmacol. Toxicol. 78:1996;37-43.
9. Singh N.P., McCoy M.T., Tice R.R., Schneider E.L. A simple technique for quantification of low levels of DNA damage in individual cells. Exp. Cell Res. 175:1988;184-191.
10. Vaghef H., Hellman B. Demonstration of chlorobenzene-induced DNA damage in mouse lymphocytes using the single-cell gel electrophoresis assay. Toxicology. 96:1995;19-28.
11. Hellman B., Vaghef H., Boström B. The concepts of tail moment and tail inertia in the single-cell gel electrophoresis assay. Mutation Res. 336:1995;123-131.
12. S. Siegel, N.J. Castellan, Non-parametric Statistics for the Behavioural Sciences, 2nd ed., McGraw-Hill, Singapore, 1988.
13. Tice R.R., Strauss G.H.S., Peters W.P. High-dose combination alkylating agents with autologous bone-marrow support in patients with breast cancer: preliminary assessment of DNA damage in individual peripheral blood lymphocytes using the single-cell gel electrophoresis assay. Mutation Res. 271:1992;101-113.
14. Hartmann A., Herkommer K., Gluck M., Speit G. DNA-damaging effect of cyclophosphamide on human blood cells in vivo and in vitro studied with the single-cell gel test (comet assay). Environ. Mol. Mutagen. 25:1995;180-187.
15. Östling O., Johanson K.J. Microelectrophoretic study of radiation-induced DNA damages in individual cells. Biochem. Biophys. Res. Commun. 123:1984;291-298.
16. McKelvey-Martin V.J., Green M.H.L., Schmezer P., Pool-Zobel B.L., De Méo M.P., Collins A. The single-cell gel electrophoresis assay (comet assay): a European review. Mutation Res. 288:1993;47-63.
17. Fairbairn D.W., Olive P.L., O'Neill K.L. The comet assay: a comprehensive review. Mutation Res. 339:1995;37-59.
18. Pool-Zobel B.L., Lotzmann N., Knoll M., Kuchenmeister F., Lambertz R., Leucht U., Schröder H.-G., Schmezer P. Detection of genotoxic effects in human gastric and nasal mucosa cells isolated from biopsy samples. Environ. Mol. Mutagen. 24:1994;23-45.
19. Hartmann A., Speit G. Genotoxic effects of chemicals in the single-cell gel (SCG) test with human blood cells in relation to induction of sister-chromatid exchanges (SCE). Mutation Res. 346:1995;49-56.
20. Monteith D.K., Vanstone J. Comparison of DNA damage from genotoxicants using the microgel electrophoresis assay with primary cultures of rat and human hepatocytes. Mutation Res. 345:1995;79-86.
21. Collins A.R., Ai-guo M., Duthie S.J. The kinetics of repair of oxidative DNA damage (strand breaks and oxidised pyrimidines) in human cells. Mutation Res. 336:1995;69-77.
22. Malcolmson A.M., Davies G., Hanson J.A., Deeley J.O.T., Gaffney C.C., McGregor D.A., Kerby I.J. Determination of radiation-induced damage in lymphocytes using the micronucleus and microgel electrophoresis 'comet' assays. Eur. J. Cancer. 31A:1995;2320-2323.
23. Fortini P., Raspaglio G., Falchi M., Dogliotti E. Analysis of DNA alkylation damage and repair in mammalian cells by the comet assay. Mutagenesis. 11:1996;169-175.
24. Lankinen M.H., Vilpo L.M., Vilpo J.A. UV- and γ-irradiation-induced DNA single-strand breaks and their repair in human blood granulocytes and lymphocytes. Mutation Res. 352:1996;31-38.
25. Olive P.L., Frazer G., Banáth J.P. Radiation-induced apoptosis measured in TK6 human B lymphoblast cells using the comet assay. Radiat. Res. 136:1993;130-136.
26. Fairbairn D.W., Walburger D.K., Fairbairn J.J., O'Neill K.L. Key morphologic changes and DNA strand breaks in human lymphoid cells: Discriminating apoptosis from necrosis. Scanning. 18:1996;407-416.
27. Olive P.L., Banáth J.P., MacPhail H.S. Lack of correlation between radiosensitivity and DNA double-strand break induction and rejoining in six human tumor cell lines. Cancer Res. 54:1994;3939-3946.
28. Olive P.L., Banáth J.P. Growth fraction measured using the comet assay. Cell Prolif. 25:1992;447-457.
29. Olive P.L., Vikse C.K., Banáth J.P. Use of the comet assay to identify cells sensitive to tirapazamine in multicell spheroids and tumours in mice. Cancer Res. 56:1996;4460-4463.
30. Abt G., Vaghef H., Gebhart E., Vallhagen Dahlgren C., Hellman B. The role of N-acetylcysteine as a putative radioprotective agent on X-ray-induced DNA damage as evaluated by alkaline single-cell gel electrophoresis. Mutation Res. 384:1997;55-64.
31. Calderón-Garcidueñas L., Osnaya-Brizuela N., Ramirez-Martinez L., Villarreal-Calderón A. DNA strand breaks in human nasal respiratory epithelium are induced upon exposure to urban pollution. Environ. Health Perspect. 104:1996;160-168.
32. Rojas E., Valverde M., Sordo M., Ostrsky-Wegman P. DNA damage in exfoliated buccal cells of smokers assessed by the single-cell gel electrophoresis assay. Mutation Res. 370:1996;115-120.
33. Friis L., Vaghef H., Edling C., Hellman B. No increased DNA damage in peripheral lymphocytes of sewage workers as evaluated by alkaline single-cell gel electrophoresis. Occup. Environ. Med. 54:1997;494-498.
34. Klaude M., Eriksson S., Nygren J., Ahnström G. The comet assay: mechanisms and technical considerations. Mutation Res. 363:1996;89-96.
35. Gurney H. Dose calculation of anticancer drugs: a review of the current practice and introduction of an alternative. J. Clin. Oncol. 14:1996;2590-2611.
36. Sandström M., Freijs A., Larsson R., Nygren P., Fjällskog M.-L., Bergh J., Karlsson M.O. Lack of relationship between systemic exposure for the component drugs of the fluorouracil, epirubicin and 4-hydroxycyclo-phosphamide regimen in breast cancer patients. J. Clin. Oncol. 14:1996;1581-1588.
37. Eastman A., Barry M.A. The origins of DNA strand breaks: A consequence of DNA damage, DNA repair or apoptosis. Cancer Invest. 10:1992;229-240.
38. Anderson D., Bishop J.B., Colin Garner R., Ostrosky-Wegman P., Selby P.B. Cyclophosphamide: Review of its mutagenicity for an assessment of potential germ cell risks. Mutation Res. 330:1995;115-181.
39. T. Raposa, SCE induction by cytostatics and its relation to iatrogenic leukemogenesis. Basic Life Sci., Part B (1984) 859-884.
40. Jacobson-Kram D., Albertini R.J., Branda R.F., Falta M.T., Iype P.T., Kolodner K., Liou S.H., McDiarmid M.A., Morris M., Nicklas J.A., O'Neill J.P., Poirier C., Putman D., Strickland P.T., Williams J.R., Xiao S. Measurement of chromosomal aberrations, sister chromatid exchanges, HPRT mutations, and DNA adducts in peripheral lymphocytes of human populations at increased risk for cancer. Environ. Health Perspect. 101(suppl. 3):1993;121-125.
41. Tucker J.D., Wyrobek A.J., Ashworth L.K., Christensen M.L., Burton G.V., Carrano A.V., Everson R.B. Induction, accumulation, and persistence of sister chromatid exchanges in women with breast cancer receiving cyclophosphamide, adriamycin, and 5-fluorouracil chemotherapy. Cancer Res. 50:1990;4951-4956.
42. Ammenhauser M.M., Ward J.B., Whorton E.B., Killian J.M., Legator M.S. Elevated frequencies of 6-thioguanine-resistant lymphocytes in multiple sclerosis patients treated with cyclophosphamide: a prospective study. Mutation Res. 204:1988;509-520.
43. Tates A.D., van Dam F.J., Natarajan A.T., Zwinderman A.H., Osanto S. Frequencies of HPRT mutations and micronuclei in lymphocytes of cancer patients under chemotherapy: A prospective study. Mutation Res. 307:1994;293-306.
44. Fruehauf J.P., Bosanquet A.G. In vitro determination of drug response: a discussion of clinical applications. PPO updates. 7:1993;16.